Valluvan Jeevanandam to Disease-Free Survival
This is a "connection" page, showing publications Valluvan Jeevanandam has written about Disease-Free Survival.
Connection Strength
0.183
-
A Fully Magnetically Levitated Left Ventricular Assist Device - Final Report. N Engl J Med. 2019 04 25; 380(17):1618-1627.
Score: 0.035
-
Decoupling Between Diastolic Pulmonary Artery Pressure and Pulmonary Capillary Wedge Pressure as a Prognostic Factor After Continuous Flow Ventricular Assist Device Implantation. Circ Heart Fail. 2017 Sep; 10(9).
Score: 0.031
-
Characterization of Ventricular Tachycardia After Left Ventricular Assist Device Implantation as Destination Therapy: A Single-Center Ablation Experience. JACC Clin Electrophysiol. 2017 12 11; 3(12):1412-1424.
Score: 0.031
-
Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure. Circulation. 2017 May 23; 135(21):2003-2012.
Score: 0.030
-
Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure. N Engl J Med. 2017 02 02; 376(5):451-460.
Score: 0.030
-
Modified HeartMate II driveline externalization technique significantly decreases incidence of infection and improves long-term survival. ASAIO J. 2014 Nov-Dec; 60(6):613-6.
Score: 0.026